Advanced search
1 file | 377.35 KB

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

(2018) LEUKEMIA. 32(1). p.244-248
Author
Organization
Keywords
NOVO PURINE SYNTHESIS, RANDOMIZED-TRIAL, TEL-AML1 FUSION, ONCOLOGY-GROUP, PHASE-3 TRIAL, THERAPY, DEXAMETHASONE, CHILDREN, PROTOCOL, CANCER

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 377.35 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Piette, C, S Suciu, E Clappier, Y Bertrand, S Drunat, S Girard, K Yakouben, et al. 2018. “Differential Impact of Drugs on the Outcome of ETV6-RUNX1 Positive Childhood B-cell Precursor Acute Lymphoblastic Leukaemia : Results of the EORTC CLG 58881 and 58951 Trials.” Leukemia 32 (1): 244–248.
APA
Piette, C., Suciu, S., Clappier, E., Bertrand, Y., Drunat, S., Girard, S., Yakouben, K., et al. (2018). Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials. LEUKEMIA, 32(1), 244–248.
Vancouver
1.
Piette C, Suciu S, Clappier E, Bertrand Y, Drunat S, Girard S, et al. Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials. LEUKEMIA. 2018;32(1):244–8.
MLA
Piette, C, S Suciu, E Clappier, et al. “Differential Impact of Drugs on the Outcome of ETV6-RUNX1 Positive Childhood B-cell Precursor Acute Lymphoblastic Leukaemia : Results of the EORTC CLG 58881 and 58951 Trials.” LEUKEMIA 32.1 (2018): 244–248. Print.
@article{8549771,
  author       = {Piette, C and Suciu, S and Clappier, E and Bertrand, Y and Drunat, S and Girard, S and Yakouben, K and Plat, G and Dastugue, N and Mazingue, F and Grardel, N and Van Roy, Nadine and Uyttebroeck, A and Costa, V and Minckes, O and Sirvent, N and Simon, P and Lutz, P and Ferster, A and Pluchart, C and Poiree, M and Freycon, C and Dresse, M-F and Millot, F and Chantrain, C and van der Werff ten Bosch, J and Norga, K and Gilotay, C and Rohrlich, P-S and Benoit, Yves and Cave, H},
  issn         = {0887-6924},
  journal      = {LEUKEMIA},
  keywords     = {NOVO PURINE SYNTHESIS,RANDOMIZED-TRIAL,TEL-AML1 FUSION,ONCOLOGY-GROUP,PHASE-3 TRIAL,THERAPY,DEXAMETHASONE,CHILDREN,PROTOCOL,CANCER},
  language     = {eng},
  number       = {1},
  pages        = {244--248},
  title        = {Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials},
  url          = {http://dx.doi.org/10.1038/leu.2017.289},
  volume       = {32},
  year         = {2018},
}

Altmetric
View in Altmetric
Web of Science
Times cited: